First outbreak of kpc-3-producing klebsiella pneumoniae (st258)clinical isolates in a mexican medical center

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 4086-4088

  Rodríguez Zulueta, Patricia ^a   Silva Sánchez, Jesús ^b   Barrios, Humberto ^b   Reyes Mar, Javier ^a   Vélez Pérez, Francisco ^a   Arroyo Escalante, Sara ^a   Ochoa Carrera, Luis ^a   Delgado Sapien, Gabriela ^c   Del Rosario Morales Espinoza, María ^c   Tamayo Legorreta, Elsa ^b   Hernández Castro, Rigoberto ^a   Garza Ramos, Ulises ^b  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; KANAMYCIN; MEROPENEM; PIPERACILLIN; TETRACYCLINE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; EPIDEMIC; HEALTH CARE FACILITY; HUMAN; KLEBSIELLA PNEUMONIAE; KPC 3 PRODUCING KLEBSIELLA PNEUMONIAE; LETTER; MEXICO; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HEALTH PERSONNEL; HOSPITALS; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MEXICO; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84880301557     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02530-12     Document Type: Letter

References (20)

1. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161.
2. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
3. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. 2011. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55:4943-4960.
4. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A. 2007. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J. Antimicrob. Chemother. 60:1124-1130.
5. Silva-Sanchez J, Reyna-Flores F, Velazquez-Meza ME, Rojas-Moreno T, Benitez-Diaz A, Sanchez-Perez A. 2011. In vitro activity of tigecycline against extended-spectrum beta-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study. Diagn. Microbiol. Infect. Dis. 70:270-273.
6. Silva-Sanchez J, Barrios H, Reyna-Flores F, Bello-Diaz M, Sanchez-Perez A, Rojas T, Garza-Ramos U. 2011. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates in Mexico. Microb. Drug Resist. 17:497-505.
7. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. Document M100-S22. CLSI, Wayne, P. A.
8. Clinical and Laboratory Standards Institute. 2010. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. M07-A9. CLSI, Wayne, P. A.
9. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. 2008. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418.
10. Kaufmann ME. 1998. Pulsed-field gel electrophoresis. Methods Mol. Med. 15:33-50.
11. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
12. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182.
13. Livermore DM. 2012. Current epidemiology and growing resistance of gram-negative pathogens. Korean J. Intern. Med. 27:128-142.
14. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
15. Vimont S, Mnif B, Fevre C, Brisse S. 2008. Comparison of PFGE and multilocus sequence typing for analysis of Klebsiella pneumoniae isolates. J. Med. Microbiol. 57:1308-1310.
16. Kieser T. 1984. Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19-36.
17. Miller JM. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
18. Garcia-Fernandez A, Fortini D, Veldman K, Mevius D, Carattoli A. 2009. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 63:274-281.
19. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. 2010. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65:2518-2529.
20. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J. 2007. Detection and spread of Escherichia coli possessing the plasmidborne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975.